Technical Analysis for VRBCF - Virbac SA

Grade Last Price % Change Price Change
grade B 234.5 -1.26% -3.0000
VRBCF closed down 1.26 percent on Friday, November 15, 2019, on 67 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical VRBCF trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -1.26%
Gapped Down Weakness -1.26%
New 52 Week Closing High Bullish -3.50%
Narrow Range Bar Range Contraction -3.50%
New 52 Week High Strength -3.50%
Gapped Up Strength -3.50%
New 52 Week Closing Low Bearish 79.01%
Older signals for VRBCF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. The company offers Canigen vaccines; Clostrisan, a vaccine for the prevention of clostridiosis and botulism; Deltanil, a deltamethrin-based parasiticide for topical application; Effitix to treat tick, flea, and mosquito infestations; Epiotic, an ear cleanser; Eradia for the treatment of clostridium infections and giardiasis; and Fort Up, an injectable solution to control and treat gastro-intestinal and pulmonary parasiticides. It also provides Iverhart and Iverhart Max Soft Chew, a chewable tablets to prevent heartworm disease, as well as treat and control roundworms, hookworms, and tapeworms; Maxflor Duo/Maxflin, an antibiotic for the prevention and treatment of respiratory diseases; Milteforan, an oral treatment for canine leishmaniosis; Moxiheart, an internal parasiticide; and Multimin, a trace element injectable supplement. In addition, the company offers Nutribond to enhance dietary; Prinovox, an ectoparasiticide; Propofol, an anesthetic; Rilexine, a cephalexin-based antibiotic; Sentinel Flavor Tabs and Sentinel Spectrum, a polyvalent parasiticide tablets; Shotapen, a combination of antibiotics to treat bacterial infections; Speed Reader, a blood marker dosage analyzer; and Suprelorin, an implant to induce temporary infertility in male dogs. Further, it provides Tridectin, a parasiticide oral solution; Veterin, an antibiotic; Veterinary HPM, a petfood; and Zoletil, a multi-species general anaesthetic. Additionally, the company is involved in the production of moldings for third parties. It operates in France, rest of Europe, North America, Latin America, Asia, Pacific, and Africa and the Middle East. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Medicine Medical Specialties RTT Infectious Diseases Africa Asia Infection Antibiotics Antibiotic Respiratory Diseases Bacterial Infections Dirofilaria Immitis Zoonoses Botulism Pacific Spirurida

Is VRBCF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 243.0
52 Week Low 131.0
Average Volume 150
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0000
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 234.5000
Resistance 3 (R3) 234.5000 234.5000 234.5000
Resistance 2 (R2) 234.5000 234.5000 234.5000 234.5000
Resistance 1 (R1) 234.5000 234.5000 234.5000 234.5000 234.5000
Pivot Point 234.5000 234.5000 234.5000 234.5000 234.5000
Support 1 (S1) 234.5000 234.5000 234.5000 234.5000 234.5000
Support 2 (S2) 234.5000 234.5000 234.5000 234.5000
Support 3 (S3) 234.5000 234.5000 234.5000
Support 4 (S4) 234.5000